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ABSTRACT 
 
Background: One of the most important steps in controlling cancer is the identification of places where cancer 
burden is more than the expected limit.  
Aim: To investigate the occurrence, distribution, and identification of high-risk lung cancer centers in Ardabil 
province. 
Methods: In this study, data from 2011-2016 were collected from the Cancer Registry Center of Ardabil.Periodic 
prevalence of the total number of cases and the incidence of new cases of the disease per 100,000 people were 
calculated. The Inverse Distance Weighting (IDW) and ArcMap GIS10.4.1 software were used to determine the 
high-risk areas. 
Results: In a 6-year period (2011-2016), 850 cases of lung cancer were registered in Ardabil Province. The 
mean(SD) age of the patients was 65.51(13.8) years. The age-standardized rate(ASR) was 70.1 for men and 42.4 
for women. the overall prevalence was 96.3 for males and 42.5 for women. The results of IDW analysis show that 
the residents of Ardabil(capital of the province) with a 21-30% probability, have the highest chance of catching and 
one of the most dangerous areas in the province. 
Conclusion: This study provides the most up-to-date information on the epidemiology of lung cancer in 
northwestern Iran, which can be used for prevention and control interventions. The incidence of lung cancer in 
men was 2.3 times higher than that of women, and the incidence of this disease in recent years has been 
increasing. The incidence rate varies in different cities of the province. 
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INTRODUCTION 
 
Cancer is one of the most important causes of mortality 
and disability worldwide1. The disease, which is one of the 
most prevalent and growing diseases, is a large part of the 
efforts of care systems2. Lung cancer is one of the most 
common types of cancer and the most important cause of 
cancer death worldwide (Southern Europe, Central and 
eastern North America, and East Asia), which imposes a 
major burden of burden3. About 17% and 9% of common 
cancers are in men and women, respectively, and 19% of 
cancer deaths are related to lung cancer4. Lung cancer is 
the deadliest cancer due to its low chances of survival, 
despite a recovery in the survival of some types of cancer 
in recent years, the 5-year survival of lung cancer is 
relatively low, and is mainly due to the late diagnosis and 
the advanced stages of the disease5. In 2012, around 1.6 
million people died of lung cancer (1.1 million deaths for 
men and 0.5 million deaths for women), mostly in less 
developed countries6. The figure is expected to reach 3 
million in 2035 (2.1 million deaths for men and 0.9 million 
deaths for women)6. Although the incidence of lung cancer 
in women is lower than that of men, it is among the 5 most 
common cancers (8.5% of all cancers) and the second 
most common cause of cancer (12.8% of all cancers) 
among women7. According to some reports, the risk of 
death from lung cancer increases with age. The mortality 
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rate for lung cancer in the age group under age 45 is 
between 1% and 8%, and in the age group above 65%, it is 
30%8,9. There is ample evidence that cigarette smoking is 
one of the most important causes of lung cancer5,10,11. But 
25% of deaths from lung cancer occur among non-
smokers10. Air pollution, a history of pulmonary diseases 
such as tuberculosis and pneumonia, high doses of radon, 
and exposure to industrial and chemical carcinogens such 
as asbestos, silica, and arsenic are other risk factors for 
lung cancer12. Due to the difference in the location-based 
environment, the incidence of cancer varies from place to 
place13,14. The emergence of Geographic Information 
System (GIS) and the production of high-resolution digital 
maps of the Earth's climatic and ecological conditions allow 
us to better identify the relationship between the 
geographical dispersion of a disease and its relation to 
climate and environmental variables, and help us to do a 
right planning for controlling and preventing it15,16 
Therefore, one of the most important cancer control 
measures is to identify places where the cancer burden is 
greater than the expected limit. The aim of this study was 
to determine the incidence, distribution, and dispersion of 
lung cancer in Ardabil province and to determine the high-
risk areas of the disease that can be useful for policy-
making and planning in order to control the burden of lung 
cancer. 
 
MATERIALS AND METHODS 
 
In this study, data on lung cancer from 2011 to 2016 were 
obtained from the Cancer Registry Center of Ardabil 
University of Medical Sciences. Age as a continuous 
variable was shown by mean and standard deviation (SD) 
and gender variable as numbers and percentages. The t-
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test was used to compare the mean age in men and 
women. The periodic outbreak of total cases during the 
2011-2016 was calculated for 100,000 people. The 
incidence rate was also obtained from new cases of the 
disease per 100,000 people. Data were analyzed using 
SPSS version 20; IBM Corp., Armonk NY, USA). 
The study area:  Ardabil Province is located in the 
northwest of Iran, bordering the Republic of Azerbaijan on 
the north. And 37.45 to 39.42 N. latitude and 47.30 to 48.55 
E. longitude and a height of 4811-15 meters above sea 
level. The population of this province in 2016 was about 
1270000 according to the statistics of the Ardabil 
Province’s the Management and Planning Organization. 
Spatial analysis and IDW: In order to determine the 
spatial dispersion and spatial analysis of lung cancer, all 
cases of disease occurred during the years of study in 
Ardabil Province and pathology confirmed by lung cancer 
were included in the study, which comprised 84 points and 
after extracting geographical coordinates, entered the 
ArcMap 10.4.1 environment, and its dispersion map was 
prepared.In addition,IDWanalysis was used to determine 
the risk areas. In this model, distance as the known 
variable weight is reversely used to predict unmeasured 
(unknown)points, meaning that as much as we get away 
from a disease point, the probability of developing the 
disease will be less. 
 
RESULTS 
 
During a 6-year period (2011-2016), 850 cases of lung 
cancer were recorded in Ardabil Province, 597 males 
(70.2%) and 253 females (29.8%). The mean (SD) age of 
the patients was 65.51 (13.8) and the median age was 67 
years. The mean (SD) age for men was 65.81 (13.31) and 
for women, it was 65 (14.51), which was not statistically 
significant (T-test; P> 0.05). the majority of pts with lung 
cancer (95%) were aged between 40-90 years (Fig. 1). 
The overall incidence of lung cancer in this study is 
65.7 per 100,000, which is 2.3 times higher in males than in 
females (96.3 in men and 42.5 in women). During these 
years, there is an increasing trend in the incidence of lung 
cancer in the province, and the incidence is different for 
men and women during these years (chi-square test; P 
<0.001) (Table 1). 
Spatial dispersion of the disease in the province 
indicates that the disease has occurred over the past six 
years in 84 areas, including 13 urban areas and 71 rural 
areas. More than 48% of cases have occurred in the 
county of Ardabil. Survey on the prevalence of the disease 
indicates that warmth with an average prevalence of 98 per 
100,000 is the most prevalent disease, and Naminwith 33 
per 100,000 has the least number of cases (Fig. 2). 
The results of the IDW analysis show that residents of 
the Ardabil urban district, which is the capital of the 
province, with a probability of 31 to 20 percent, have the 
highest incidence of lung cancer and is considered as a 
high-risk region so that its extension is extending to the 
south of the province. In addition, the north side of the city 
of Parsabad, Germiand Meshginshahr, with a probability of 
4-10%, are among the areas at risk in the province with 
regard to lung cancer (Fig. 3). 
 
Fig. 1. Age distributionofthestudy population 
 
 
Table 1. Demographic and epidemiological characteristics in patients with lung cancer Spatial 
Population 
studied 
N Age(SD) 
(Min–Max( 
pp Ir 
2010–11 
Ir 
2011–12 
Ir 
2012–13 
Ir 
2013–14 
Ir 
2014–15 
Ir 
2015–16 
Male  
597 
65.81(13.31) 
(21-95) 
96.3 12.6 13.7 15.2 16.9 17.7 20.2 
Female 
253 
65.02(14.51) 
(13-92) 
42.5 10 5.3 5.5 6.1 7.4 8.2 
Total 
850 
65.57(13.68) 
(13-95) 
65.7 10.9 8.7 10.4 9.7 12.2 13.9 
15 10 5 0 5 10 15
0-4
10-14
20-24
30-34
40-44
50-54
60-64
70-74
80-84
%Female %Male
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Fig. 2. The outbreak of lung cancer in Ardabil Province 
 
 
Fig 3. IDW analysis of high-risk areas for lung cancer in Ardabil Province 
 
DISCUSSION 
 
Regional information on cancer patterns is an essential 
basis for identifying prevention and control priorities for 
cancer. This study was conducted to obtain regional and 
geographical information on lung cancer in Ardabil 
Province. The median age of patients with lung cancer in 
this study was 67 years (with a mean of 65.5%), indicating 
the pattern of the disease in Ardabil Province appears in 
middle age. More than 95% of patients were between the 
ages of 40-90. In the study conducted by Ghamari et al., 
the average age was 65.7%, and also, about 94% were in 
the age range of 40-90 years, which is consistent with the 
results of this study17. Also, in the study conducted by 
Ridge et al., the median age of patients with lung cancer 
was 67 years and about 90% are in the age range of 35-90 
years18. In the study conducted by Ghamari et al., 20 
patients under 20 years of age were diagnosed17. In this 
study, there was only one patient under the age of 20 
years, which this result was consistent with Ridge et al.’s 
study18. As a result, the incidence of the disease among 
people under 20 years in Ardabil Province is much lower 
than in other regions. The data showed that as age 
increases, the incidence of lung cancer increases, as well, 
but it decreases after age 80. Other studies have also 
shown that the incidence of cancers in adults is less than 
75 years of age13,17. This can be due to a reduction in the 
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proportion of the population in this age group or due to 
illness and morbidity, which reduces the diagnosis of 
cancer in this age. According to the Table 1, there has 
been an increasing trend in lung cancer in the province 
from 2011 to 2016, so that it increased from 10.9 per 
100,000 to 13.9 per 100,000 people. Perhaps this increase 
in the incidence of illness is due to improved diagnostic 
methods in recent years or increased air pollution, 
environmental changes, and other causes. Other studies 
have also shown an increasing trend in the incidence of 
cancer in recent years (13, 19, 20). Studies that have 
focused on lung cancer, have also confirmed the increasing 
incidence of lung cancer in recent years, especially in 
developed countries (21-24). The trend for an increased 
incidence of lung cancer was higher in men than in women, 
and for 5 years, it increased from 12.6 to 20.2 per 100,000 
people. In the study conducted by Ghamari et al., the 
increased incidence of lung cancer was higher in men than 
in women(17). In this study, men were more likely than 
women to have lung cancer, so that the periodic outbreak 
in men was 2.5 times more than in women (96.3 for men 
and 42.5 for women). Because in terms of occupational 
and exposure to environmental risk factors, men are more 
likely to be at risk than women. Also, high levels of smoking 
in men are a possible contributing factor. In a study of lung 
cancer patients, Naghan PA et al. found that 74% of 
patients with lung cancer were men, and men were 2.8 
times more likely than women for catching the disease(21). 
Furthermore, in a study of the incidence of lung cancer, 
Vardanjani et al. showed that the incidence of lung cancer 
in men was 2 times higher than in women (67% of the 
patients were male) (22). In the study of lung cancer, 
Ghamari et al. concluded that lung cancer in men is 2.5 
times more than in women(17). A comparison between the 
results of all these studies with the results of the present 
study shows that in all regions of the world, the incidence of 
lung cancer in males is higher than in women. The spatial 
analysis of data in the region showed a different distribution 
pattern of lung cancer in Ardabil province. The highest 
incidence of lung cancer (42% of cases) in both genders 
occurred in Ardabil city. The results of the IDW analysis 
also show that Ardabil has the highest risk of lung cancer, 
and residents of this region have a high chance of getting 
the disease, which this could be because the county of 
Ardabil is the capital of the province as well as to be 
industrialized, which increased the risk of cancer. In 
another study in Fars Province (another province of Iran), 
spatial analysis of cancer data obtained the highest ASR 
for the provincial capital(25). Another study conducted to 
investigate the distribution of cancer cases in Isfahan 
province (another province in Iran), shows that the highest 
incidence of cancer is in the capital of the province13 
 
CONCLUSION 
 
This study provides the latest information on the 
epidemiology of lung cancer in northwestern Iran, which 
can be used for prevention and control interventions. The 
incidence of lung cancer in men was 2.3 times higher than 
in women, and the incidence of this disease has increased 
in recent years. The incidence rate is different in different 
cities of the province, and the risk in the provincial capital is 
greater, and Ardabil is one of the high-risk areas of lung 
cancer in the province, which should be considered in the 
large-scale planning of disease control and prevention. 
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